[1]
Barber HW. Case of Fox-Fordyce Disease. Proceedings of the Royal Society of Medicine. 1922:15(Dermatol Sect):44-5
[PubMed PMID: 19982255]
Level 3 (low-level) evidence
[2]
Miller ML, Harford RR, Yeager JK. Fox-Fordyce disease treated with topical clindamycin solution. Archives of dermatology. 1995 Oct:131(10):1112-3
[PubMed PMID: 7574824]
[3]
Guiotoku MM, Lopes PT, Marques ME, Marques SA, Miot HA. Fox-Fordyce disease in monozygotic female twins. Journal of the American Academy of Dermatology. 2011 Jul:65(1):229-30. doi: 10.1016/j.jaad.2009.11.591. Epub
[PubMed PMID: 21679831]
[4]
GRAHAM JH, SHAFER JC, HELWIG EB. Fox-Fordyce disease in male identical twins. Archives of dermatology. 1960 Aug:82():212-21
[PubMed PMID: 13828810]
[5]
Scroggins L, Kelly E, Kelly B. Fox-Fordyce disease in daughter and father. Dermatology (Basel, Switzerland). 2009:218(2):176-7. doi: 10.1159/000182271. Epub 2008 Dec 5
[PubMed PMID: 19060475]
[6]
Turner TW. Hormonal levels in Fox-Fordyce disease. The British journal of dermatology. 1976 Mar:94(3):317-8
[PubMed PMID: 1252362]
[7]
Sammour R, Nasser S, Debahy N, El Habr C. Fox-Fordyce Disease: An under-diagnosed adverse event of laser hair removal? Journal of the European Academy of Dermatology and Venereology : JEADV. 2016 Sep:30(9):1578-82. doi: 10.1111/jdv.13680. Epub 2016 May 2
[PubMed PMID: 27135989]
[8]
Bernad I, Gil P, Lera JM, Giménez de Azcárate A, Irarrazaval I, Idoate MÁ. Fox Fordyce disease as a secondary effect of laser hair removal. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology. 2014 Jun:16(3):141-3. doi: 10.3109/14764172.2013.854630. Epub 2013 Nov 18
[PubMed PMID: 24131099]
[9]
Tetzlaff MT, Evans K, DeHoratius DM, Weiss R, Cotsarelis G, Elenitsas R. Fox-Fordyce disease following axillary laser hair removal. Archives of dermatology. 2011 May:147(5):573-6. doi: 10.1001/archdermatol.2011.103. Epub
[PubMed PMID: 21576577]
[10]
Helou J, Maatouk I, Moutran R, Obeid G. Fox-Fordyce-like disease following laser hair removal appearing on all treated areas. Lasers in medical science. 2013 Jul:28(4):1205-7. doi: 10.1007/s10103-012-1263-4. Epub 2013 Jan 15
[PubMed PMID: 23318918]
[11]
Shackelton J, English JC 3rd. Fox-Fordyce Disease (Apocrine Miliaria). Journal of pediatric and adolescent gynecology. 2011 Jun:24(3):108-9
[PubMed PMID: 21751451]
[12]
Salloum A, Bouferraa Y, Bazzi N, Bou Zerdan M, Abi Chebl J, Chu T, Bachour J, Benedetto A. Pathophysiology, clinical findings, and management of Fox-Fordyce disease: A systematic review. Journal of cosmetic dermatology. 2022 Feb:21(2):482-500. doi: 10.1111/jocd.14135. Epub 2021 Apr 18
[PubMed PMID: 33817950]
Level 1 (high-level) evidence
[13]
Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. Journal of the American Academy of Dermatology. 2003 Mar:48(3):453-5
[PubMed PMID: 12637930]
[14]
Yazganoğlu KD, Yazici S, Büyükbabani N, Ozkaya E. Axillary Fox-Fordyce-like disease induced by laser hair removal therapy. Journal of the American Academy of Dermatology. 2012 Oct:67(4):e139-40. doi: 10.1016/j.jaad.2011.11.925. Epub
[PubMed PMID: 22980266]
[15]
CORNBLEET T. Pregnancy and apocrine gland diseases: hidradenitis, Fox-Fordyce disease. A.M.A. archives of dermatology and syphilology. 1952 Jan:65(1):12-9
[PubMed PMID: 14877283]
[16]
Ebling FJ. Apocrine glands in health and disorder. International journal of dermatology. 1989 Oct:28(8):508-11
[PubMed PMID: 2684877]
[17]
Vega-Memije ME, Pérez-Rojas DO, Boeta-Ángeles L, Valdés-Landrum P. Fox-Fordyce disease: report of two cases with perifollicular xanthomatosis on histological image. Anais brasileiros de dermatologia. 2018 Jul-Aug:93(4):562-565. doi: 10.1590/abd1806-4841.20187475. Epub
[PubMed PMID: 30066765]
Level 3 (low-level) evidence
[18]
Brau Javier CN, Morales A, Sanchez JL. Histopathology attributes of Fox-Fordyce disease. International journal of dermatology. 2012 Nov:51(11):1313-8. doi: 10.1111/j.1365-4632.2011.05236.x. Epub
[PubMed PMID: 23067079]
[19]
Bormate AB Jr, Leboit PE, McCalmont TH. Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases. Archives of dermatology. 2008 Aug:144(8):1020-4. doi: 10.1001/archinternmed.2008.3. Epub
[PubMed PMID: 18711075]
[20]
Singal A, Kaur I, Jakhar D. Fox-Fordyce Disease: Dermoscopic Perspective. Skin appendage disorders. 2020 Jul:6(4):247-249. doi: 10.1159/000508201. Epub 2020 Jun 9
[PubMed PMID: 32903893]
Level 3 (low-level) evidence
[21]
Blasco-Morente G, Naranjo-Díaz MJ, Pérez-López I, Martínez-López A, Ruiz-Villaverde R, Aneiros-Fernández J. Fox-Fordyce Disease. Sultan Qaboos University medical journal. 2016 Feb:16(1):e119-20. doi: 10.18295/squmj.2016.16.01.025. Epub 2016 Feb 2
[PubMed PMID: 26909204]
[22]
. In vivo features of Fox-Fordyce disease in high-definition optical coherence tomography. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016 Mar:14(3):340. doi: 10.1111/ddg.13002. Epub
[PubMed PMID: 26972218]
[23]
Liu WC, Cao T, Ho MS, Chong WS, Lee JS. In vivo features of Fox-Fordyce disease in high-definition optical coherence tomography. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016 Jan:14(1):62-3. doi: 10.1111/ddg.12688. Epub
[PubMed PMID: 26713641]
[24]
George A, Bhatia A, Thomas E. Fox-Fordyce disease: a report of 2 cases responding to topical clindamycin. Indian journal of dermatology, venereology and leprology. 2015 Jan-Feb:81(1):87-8. doi: 10.4103/0378-6323.148597. Epub
[PubMed PMID: 25566917]
Level 3 (low-level) evidence
[25]
Kaya Erdoğan H, Bulur I, Kaya Z. Clinical Effects of Topical Tacrolimus on Fox-Fordyce Disease. Case reports in dermatological medicine. 2015:2015():205418. doi: 10.1155/2015/205418. Epub 2015 Jun 15
[PubMed PMID: 26171257]
[26]
Milcic D, Nikolic M. Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease. The Australasian journal of dermatology. 2012 May:53(2):e34-5. doi: 10.1111/j.1440-0960.2010.00711.x. Epub 2010 Nov 9
[PubMed PMID: 22571582]
Level 3 (low-level) evidence
[27]
Pock L, Svrcková M, Machácková R, Hercogová J. Pimecrolimus is effective in Fox-Fordyce disease. International journal of dermatology. 2006 Sep:45(9):1134-5
[PubMed PMID: 16961542]
[28]
Giacobetti R, Caro WA, Roenigk HH Jr. Fox-Fordyce disease. Control with tretinoin cream. Archives of dermatology. 1979 Nov:115(11):1365-6
[PubMed PMID: 507892]
[29]
Kassuga LE, Medrado MM, Chevrand NS, Salles Sde A, Vilar EG. Fox-Fordyce disease: response to adapalene 0.1%. Anais brasileiros de dermatologia. 2012 Mar-Apr:87(2):329-31
[PubMed PMID: 22570049]
[30]
Effendy I, Ossowski B, Happle R. Fox-Fordyce disease in a male patient--response to oral retinoid treatment. Clinical and experimental dermatology. 1994 Jan:19(1):67-9
[PubMed PMID: 8313643]
Level 2 (mid-level) evidence
[31]
Lansang RP, Lam M, Jakubovic HR, Shukla R. Fox-Fordyce disease treated with fractional CO2 laser: A case report. JAAD case reports. 2023 Jul:37():5-7. doi: 10.1016/j.jdcr.2023.04.028. Epub 2023 May 10
[PubMed PMID: 37332362]
Level 3 (low-level) evidence
[32]
Alhameedy MM, Tariq MU. Refractory pruritic Fox-Fordyce disease successfully treated with botulinum toxin type A. International journal of women's dermatology. 2022 Oct:8(3):e039. doi: 10.1097/JW9.0000000000000039. Epub 2022 Aug 11
[PubMed PMID: 35966823]
[33]
Han HH, Lee JY, Rhie JW. Successful treatment of areolar Fox-Fordyce disease with surgical excision and 1550-nm fractionated erbium glass laser. International wound journal. 2016 Oct:13(5):1016-9. doi: 10.1111/iwj.12586. Epub 2016 Apr 12
[PubMed PMID: 27072751]
[34]
Uzuncakmak TK, Karadag AS, Ozlu E, Akdeniz N, Cobanoglu Simsek B. Effective treatment of Fox-Fordyce disease with pulsed dye laser. Photodermatology, photoimmunology & photomedicine. 2016 Sep:32(5-6):311-313. doi: 10.1111/phpp.12272. Epub 2016 Sep 28
[PubMed PMID: 27623097]
[35]
González-Ramos J, Alonso-Pacheco ML, Goiburú-Chenú B, Mayor-Ibarguren A, Herranz-Pinto P. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A. The British journal of dermatology. 2016 Feb:174(2):458-9. doi: 10.1111/bjd.14180. Epub 2015 Nov 18
[PubMed PMID: 26385128]
[36]
Ahmed Al-Qarqaz F, Al-Shannag R. Fox-Fordyce disease treatment with fractional CO2 laser. International journal of dermatology. 2013 Dec:52(12):1571-2. doi: 10.1111/j.1365-4632.2011.05294.x. Epub
[PubMed PMID: 24261728]
[37]
Chae KM, Marschall MA, Marschall SF. Axillary Fox-Fordyce disease treated with liposuction-assisted curettage. Archives of dermatology. 2002 Apr:138(4):452-4
[PubMed PMID: 11939804]
[38]
Taylor D, Au J, Boen M, Fox S, Aronson IK, Jacob C. A novel modality using microwave technology for the treatment of Fox-Fordyce disease (FFD). JAAD case reports. 2016 Jan:2(1):1-3. doi: 10.1016/j.jdcr.2015.09.021. Epub 2015 Dec 24
[PubMed PMID: 27051811]
[39]
Alnoshan A, Almazied M, Alghamdi L. Fox-fordyce disease: Pulsed dye laser versus fractional Co(2) laser treatment. JAAD case reports. 2023 Oct:40():129-131. doi: 10.1016/j.jdcr.2023.08.025. Epub 2023 Aug 30
[PubMed PMID: 37781502]
Level 3 (low-level) evidence
[40]
Roga G, Bhat I. Axillary syringomas mimicking Fox-Fordyce disease. Indian dermatology online journal. 2015 Sep-Oct:6(5):376-7. doi: 10.4103/2229-5178.164476. Epub
[PubMed PMID: 26500884]
[41]
Mahajan R, Bang D, Nagar A, Bilimoria F. Rare sweat gland tumors of vulva: Report of two cases. Indian journal of sexually transmitted diseases and AIDS. 2012 Jul:33(2):124-7. doi: 10.4103/0253-7184.102128. Epub
[PubMed PMID: 23188940]
[43]
Kelati A, Aqil N, Mernissi FZ. Dermoscopic Findings and Their Therapeutic Implications in Trichostasis Spinulosa: A Retrospective Study of 306 Patients. Skin appendage disorders. 2018 Oct:4(4):291-295. doi: 10.1159/000486541. Epub 2018 Feb 13
[PubMed PMID: 30410899]
[44]
Kabiri S, Pourazizi M, Abtahi-Naeini B. Can Fractionated Microneedle Radiofrequency be an Effective Procedure for Treatment of Fox-Fordyce Disease? A Medical Hypothesis. Advanced biomedical research. 2018:7():71. doi: 10.4103/abr.abr_288_16. Epub 2018 Apr 24
[PubMed PMID: 29862220]
[45]
Naeini FF, Saffaei A, Pourazizi M, Abtahi-Naeini B. Histopathological evidence of efficacy of microneedle radiofrequency for treatment of axillary hyperhidrosis. Indian journal of dermatology, venereology and leprology. 2015 May-Jun:81(3):288-90. doi: 10.4103/0378-6323.154789. Epub
[PubMed PMID: 25851757]
[46]
Seo KY, Yoon MS, Kim DH, Lee HJ. Skin rejuvenation by microneedle fractional radiofrequency treatment in Asian skin; clinical and histological analysis. Lasers in surgery and medicine. 2012 Oct:44(8):631-6. doi: 10.1002/lsm.22071. Epub 2012 Aug 30
[PubMed PMID: 22936274]